email
register here
password
new password
privacy policy
|
imprint | copyright
search
analysis
Meta-analyses-DataBase
2603 publications
< back to search
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: 16 Week Results of a Phase 3 Randomized, Double-Blind, Placebo Controlled Trial in Patients with Prior Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.
Deodhar, Atul Poddubnyy, Denis Pacheco-Tena, Cesar Salvarani, Carlo Lespessailles, Eric Rahman, Proton Jarvinen, Pentti Sanchez-Burson, Juan Gaffney, Karl Lee, Eun Bong Krishnan, Eswar Santisteban, Silvia Li, Xiaoqi Zhao, Fangyi Carlier, Hilde Reveille, John D
published in:
Arthritis & rheumatology (Hoboken, N.J.)
abstract
endpoint
Ixekizumab has (optional: compared with placebo) proved to be better.
general condition better
basics
diagnosis:
ankylosing spondylitis
localization:
not specified
method:
conservative therapy → injection therapy
conservative therapy → injection therapy
conservative therapy → injection
publication details
DOI
10.1002/art.40753
linked to
pubmed
exernal index
30343531
year of publication
2018
journal type
Journal Article
publication type
randomized controlled trial
multicenter
yes
view
prospective
level of evidence
1+
▼
▲